Multiplex IHC Detection Platform

A microarray-based chemiluminescence immunoassay platform using hard-substrate glass slides as carriers with covalently bound monoclonal antibodies. The platform features integrated positive and negative quality control points, multi-parameter detection with up to 56 array points, and a sandwich immunoassay methodology. It combines high-sensitivity chemiluminescence detection with high-throughput biochip technology using an integrated photoelectric sensor to read all signal points simultaneously.

Immunofluorescence-based diagnostic platform for detection and identification of specific antigens or antibodies in clinical samples. Provides fluorescence-based results for rapid point-of-care and laboratory testing.

A diagnostic platform for point-of-care testing (POCT) that uses immunofluorescence technology for rapid and accurate detection. The platform features precise temperature control, multiple connectivity options, and automatic sample identification to enable quick diagnostic testing.

Automated immunoassay system utilizing electrochemical detection methods for biomarker quantification. Suitable for high-throughput clinical laboratory applications.

Point-of-care platform enabling simultaneous quantification of up to 8 biomarkers from 20-50 µl of capillary blood in 15 minutes. CE-IVD and IVDR certified technology designed for OEM integration and personalized medicine applications.

A proprietary platform enabling comprehensive multi-biomarker testing in one integrated workflow. Designed for robust molecular precision diagnostics in oncology and clinical research.

An innovative molecular detection platform utilizing microfluidic PCR technology capable of completing nucleic acid rapid detection within 30 minutes with high sensitivity and high specificity. The reagents are stable at room temperature without requiring cold chain storage, support customized multiplex detection, and can simultaneously detect up to 48 targets, providing an efficient solution for multi-pathogen detection.

Proprietary microarray technology platform for immunological testing and allergen detection. Enables high-throughput analysis of biological markers in clinical diagnostics.

An immunoblot technology platform for protein detection and analysis in clinical diagnostics. The system utilizes antibody-based detection methods for identification of specific antigens in patient samples.

A CE-IVD certified rapid test platform that enables fully automated quantification of up to 8 (or 16) biomarkers in parallel from capillary blood or other specimens. The system combines accelerated hybridization through novel microfluidics technology with chemiluminescence-based optical detection and automated reagent dispensing via cartridge system. It is designed for point-of-care multiplex testing applications, allowing customers to perform laboratory ELISA tests faster with smaller sample volumes.

Automated platform for molecular diagnostics of infectious pathogens. Integrates nucleic acid extraction and amplification for rapid disease identification.

Advanced multiplex immunoassay platform combining exclusive surface functionalization and printing technology for ultra-precise analyte detection. Accessible and scalable for implementation on standard laboratory instrumentation.